2022 annual financial data
Tenax Therapeutics 2022 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -11,052,643 USD and net income was -11,047,895 USD.
Operating cash flow was -12,012,873 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,052,643 USD
- Net income
- -11,047,895 USD
- Operating cash flow
- -12,012,873 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Tenax Therapeutics financial years